Ann M. Veneman, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 700 shares at $137.74 ($96K) on 2017-07-31, disclosed to the SEC on 2017-08-02.
Open-market sale of $96k ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2014-12-15 | $238K | — | Filing → |
| ALXN | SELL | 2014-06-06 | $210K | — | Filing → |
| ALXN | SELL | 2013-05-01 | $308K | — | Filing → |